Technical Analysis for CNCR - Loncar Cancer Immunotherapy ETF

Grade Last Price % Change Price Change
grade D 22.13 1.61% 0.35
CNCR closed up 1.61 percent on Friday, February 15, 2019, on 63 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical CNCR trend table...

Date Alert Name Type % Chg
Feb 15 Overbought Stochastic Strength 0.00%
Feb 14 Narrow Range Bar Range Contraction 1.61%
Feb 14 NR7 Range Contraction 1.61%
Feb 14 Inside Day Range Contraction 1.61%
Feb 14 Overbought Stochastic Strength 1.61%
Feb 13 Shooting Star Candlestick Bearish 2.41%
Feb 13 Stochastic Reached Overbought Strength 2.41%
Feb 13 Overbought Stochastic Strength 2.41%
Feb 12 Narrow Range Bar Range Contraction 2.36%
Feb 12 NR7 Range Contraction 2.36%

Older signals for CNCR ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.
Exchange Traded Funds Biotechnology Cancer Betashares SPDR Biotechnology Sectors Loncar Cancer Immunotherapy Index
Is CNCR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 32.32
52 Week Low 16.87
Average Volume 17,486
200-Day Moving Average 23.2465
50-Day Moving Average 20.2169
20-Day Moving Average 20.8876
10-Day Moving Average 21.5068
Average True Range 0.4257
ADX 21.31
+DI 43.6143
-DI 19.7661
Chandelier Exit (Long, 3 ATRs ) 20.8629
Chandelier Exit (Short, 3 ATRs ) 21.0571
Upper Bollinger Band 22.3366
Lower Bollinger Band 19.4386
Percent B (%b) 0.93
BandWidth 13.87426
MACD Line 0.4557
MACD Signal Line 0.3539
MACD Histogram 0.1018
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.64
Resistance 3 (R3) 22.59 22.36 22.56
Resistance 2 (R2) 22.36 22.23 22.39 22.53
Resistance 1 (R1) 22.25 22.15 22.31 22.30 22.50
Pivot Point 22.02 22.02 22.05 22.05 22.02
Support 1 (S1) 21.91 21.89 21.97 21.96 21.76
Support 2 (S2) 21.68 21.81 21.71 21.73
Support 3 (S3) 21.57 21.68 21.71
Support 4 (S4) 21.62